This highly under-rated pharmaceutical stock breaking out this week from very narrow consolidation happening since past couple of months. Could break its ATH in this rally. Let's see.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.